Compare Enveric Biosciences Inc (ENVB) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Enveric Biosciences Inc trades at $1.48 (market cap $6.80M), while Halozyme Therapeutics Inc. Common Stock trades at $112.45 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 1850× Enveric Biosciences Inc's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| ENVB | HALO | |
|---|---|---|
Market Cap | $6.80M | $12.58B |
Volume | 64,867 | 2,179,278 |
Sector | Health | Health |
52-Week High | $10.80 | $115.22 |
52-Week Low | $1.27 | $61.63 |
Typical Hold Time | 14 Days | 0 Days |
Enterprise Value | -$1.49M | $14.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.45, down 3.01% on the day, with a bearish technical signal driven by moving averages. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten quarterly EPS expectations. Recent positive developments include a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in investor conferences.
The outlook is mixed; analyst consensus is 75% buy with strong earnings beats, but high negative ROE/ROA and operational cash burn pose significant risks. Investment opportunity hinges on successful drug development, while key risks include funding needs and clinical trial outcomes.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
